(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

COLOSENSE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

COLOSENSE

ST13

US500000097978982

Class

5, 44

Filing

97978982

Registration

7553527

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

40

Latest update

10/29/2024

Trademark type

Word

Nice classes

5, 44

Filing date

11/11/2021

Registration date

10/29/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/29/2024

Last transaction

10/29/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/01/2023

First use in commerce

09/01/2023

Drawing code

4

Owner type

03

Owner location

St. Louis, MO, US

Examiner

FRIEDMAN, LESLEE ANN

Law office

N20

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Geneoscopy, Inc.
Geneoscopy, LLC

Representatives

Matthew J. Smith POLSINELLI PC

Technical classification

Nice Classes

Class 5Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Diagnostic biomarkers for medical purposes for detecting cancer; Diagnostic preparations for medical purposes; biological preparations for the treatment of cancer

Class 44

Medical screening services in the field of cancer; Medical analysis for the diagnosis and treatment of cancer; medical diagnostic testingmonitoring and reporting services; medical testing for diagnostic or treatment purposes in the field of cancer; Health care servicesfor treating cancer; medical diagnosis and treatment of cancer; medical diagnosis of cancer; medical evaluation of cancer; medical services in the field of cancer; medical diagnostic services in the field of testing for cancer markersincluding in a patient's excrement such as stool samples; providing a website featuring information in the field of the diagnosis and treatment of cancer; providing cancer screening services; providing information in the field of cancer preventionscreeningdiagnosis and treatment; providing an on-line computer database in the field of cancer information for treatment and diagnostic purposes; providing information relating to diagnostics in the nature of medical diagnostic testingmonitoring and reporting information

Publications

History of USPTO decisions and trademark events.

40 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/29/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

10/29/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/25/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/25/2024

DPCC

DIVISIONAL PROCESSING COMPLETE

09/24/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/19/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/16/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

06/18/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

06/18/2024

DRRR

DIVISIONAL REQUEST RECEIVED

05/14/2024

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

05/14/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/19/2024

GNRT

NON-FINAL ACTION E-MAILED

03/19/2024

CNRT

SU - NON-FINAL ACTION - WRITTEN

03/19/2024

DOCK

ASSIGNED TO EXAMINER

02/20/2024

CHPB

POST PUBLICATION AMENDMENT - ENTERED

02/12/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

01/08/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

01/06/2024

IUAF

USE AMENDMENT FILED

12/18/2023

EISU

TEAS STATEMENT OF USE RECEIVED

12/18/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/22/2023

EX1G

SOU EXTENSION 1 GRANTED

06/20/2023

EXT1

SOU EXTENSION 1 FILED

06/20/2023

EEXT

SOU TEAS EXTENSION RECEIVED

06/20/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/20/2022

APET

ASSIGNED TO PETITION STAFF

12/07/2022

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

11/16/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/25/2022

PUBO

PUBLISHED FOR OPPOSITION

10/25/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/05/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/19/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/16/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/15/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/15/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/29/2022

GNRT

NON-FINAL ACTION E-MAILED

08/29/2022

CNRT

NON-FINAL ACTION WRITTEN

08/29/2022

DOCK

ASSIGNED TO EXAMINER

08/23/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/18/2021

NWAP

NEW APPLICATION ENTERED

11/15/2021

Continuous trademark protection

Get notified about every new filing that threatens COLOSENSE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.